Edition:
United Kingdom

Audentes Therapeutics Inc (BOLD.OQ)

BOLD.OQ on NASDAQ Stock Exchange Global Market

33.51USD
16 Feb 2018
Change (% chg)

$-0.78 (-2.27%)
Prev Close
$34.29
Open
$34.11
Day's High
$34.11
Day's Low
$33.32
Volume
50,847
Avg. Vol
111,538
52-wk High
$41.80
52-wk Low
$14.00

Consensus Recommendations

Consensus Recommendation Next Earnings (approx.) Company Fiscal Year
End Month
Last Updated
Outperform -0.91 December 17 Feb 2018

Analyst Recommendations and Revisions

1-5 Linear Scale Current 1 Month
Ago
2 Month
Ago
3 Month
Ago
(1) BUY 4 4 4 4
(2) OUTPERFORM 4 4 3 1
(3) HOLD 2 2 2 2
(4) UNDERPERFORM 0 0 0 0
(5) SELL 0 0 0 0
No Opinion 0 0 0 0
Mean Rating 1.80 1.80 1.78 1.71

Consensus Estimates Analysis

Sales and Profit Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
  # of Estimates Mean High Low 1 Year
Ago
SALES (in millions)
Quarter Ending Mar-18 6 0.00 0.00 0.00 0.00
Quarter Ending Jun-18 6 0.00 0.00 0.00 0.00
Year Ending Dec-18 9 0.00 0.00 0.00 0.00
Earnings (per share)
Quarter Ending Mar-18 8 -0.91 -0.78 -1.24 -0.54
Quarter Ending Jun-18 8 -0.93 -0.77 -1.30 -0.53
Year Ending Dec-18 9 -3.70 -3.20 -5.31 -3.76
LT Growth Rate (%) 1 -2.10 -2.10 -2.10 2.60

Historical Surprises

Sales and Profit Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
Estimates vs Actual Estimate Actual Difference Surprise %
SALES (in millions)
Quarter Ending Sep-17 0.00 0.00 0.00 0.00
Quarter Ending Jun-17 0.00 0.00 0.00 0.00
Quarter Ending Mar-17 0.00 0.00 0.00 0.00
Quarter Ending Dec-16 0.00 0.00 0.00 0.00
Quarter Ending Sep-16 0.00 0.00 0.00 0.00

Consensus Estimates Trend

Sales and Profit Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
  Current 1 Week
Ago
1 Month
Ago
2 Month
Ago
1 Year
Ago
SALES (in millions)
Quarter Ending Mar-18 0.00 0.00 0.00 0.00 0.00
Quarter Ending Jun-18 0.00 0.00 0.00 0.00 0.00
Year Ending Dec-18 0.00 0.00 0.00 0.00 0.00

Estimates Revisions Summary

  Last Week Last 4 Weeks
Number Of Revisions: Up Down Up Down
Revenue
Quarter Ending Mar-18 0 0 0 0
Quarter Ending Jun-18 0 0 0 0
Year Ending Dec-18 0 0 0 0
Earnings